• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Tops 5,000; PepsiCo Posts Upbeat Earnings

    2/9/24 9:45:44 AM ET
    $BTAI
    $NSTG
    $PEP
    $PLCE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $BTAI alert in real time by email

    U.S. stocks traded mixed this morning, with the S&P 500 topping the 5,000 mark on Friday.

    Following the market opening Friday, the Dow traded down 0.05% to 38,706.33 while the NASDAQ rose 0.32% to 15,844.63. The S&P 500 also rose, gaining, 0.11% to 5,003.51.

    Check This Out: How To Earn $500 A Month From Principal Financial Group Stock Ahead Of Q4 Print

     

    Leading and Lagging Sectors

     

    Energy shares rose by 0.5% on Friday.

    In trading on Friday, consumer staples shares fell by 0.6%.

     

    Top Headline

     

    PepsiCo, Inc. (NASDAQ:PEP) posted better-than-expected earnings for its fourth quarter.

    The company reported fourth-quarter FY23 sales of $27.85 billion, missing the analyst consensus estimate of $28.40 billion. Sales declined 0.5% on a year-over-year basis. The company reported adjusted EPS of $1.78 in the fourth quarter, beating the street view of $1.72.

    For 2024, the company expects at least a 4% increase in organic revenue, with at least an 8% increase in core constant currency EPS.

     

    Equities Trading UP

     

    Sunworks, Inc. (NASDAQ:SUNW) shares shot up 203% to $0.1680. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware.

    Shares of TOP Financial Group Limited (NASDAQ:TOP) got a boost, surging 135% to $7.69.

    NanoString Technologies, Inc. (NASDAQ:NSTG) shares were also up, gaining 75% to $0.2039 after the company disclosed completion of financing to support restructuring process.

     

    Equities Trading DOWN

     

    The Children's Place, Inc. (NASDAQ:PLCE) shares dropped 53% to $9.19 after the company said it expects fourth-quarter net sales to be roughly $454 million to $456 million, versus its prior guidance of $460 million to $465 million, and below the estimate of $462.88 million.

    Shares of Synlogic, Inc. (NASDAQ:SYBX) were down 52% to $1.6701 after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.

    BioXcel Therapeutics, Inc. (NASDAQ:BTAI) was down, falling 35% to $2.45 after the company announced a proposed public offering.

    Also Check This Out: Top 5 Health Care Stocks That Are Preparing To Pump In February

     

    Commodities

     

    In commodity news, oil traded up 6.3% to $76.86 while gold traded down 0.4% at $2,039.40.

    Silver traded down 0.5% to $22.525 on Friday while copper fell 0.8% to $3.6715.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 fell 0.1% while Spain’s IBEX 35 Index fell 0.1% The German DAX fell 0.1% French CAC 40 fell 0.2% while Italy’s FTSE MIB Index gained 0.4%.

    Industrial production in Italy increased by 1.1% month-over-month in December, while German consumer price inflation came in at 2.9% year-over-year in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Friday, with Japan’s Nikkei 225 gaining 0.09%, Hong Kong’s Hang Seng Index falling 0.83% and India’s S&P BSE Sensex gaining 0.20%.

     

    Economics

     

    The CPI in the U.S. rose 0.2% month-over-month in December, compared to a 0.3% rise initially reported, according to revised figures from the BLS.

    Now Read This: Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'

    Get the next $BTAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTAI
    $NSTG
    $PEP
    $PLCE

    CompanyDatePrice TargetRatingAnalyst
    PepsiCo Inc.
    $PEP
    1/16/2026$179.00Neutral → Outperform
    BNP Paribas Exane
    PepsiCo Inc.
    $PEP
    12/10/2025$164.00Neutral → Overweight
    Analyst
    PepsiCo Inc.
    $PEP
    10/21/2025$167.00Hold → Buy
    DZ Bank
    PepsiCo Inc.
    $PEP
    4/15/2025$155.00Buy → Neutral
    BofA Securities
    PepsiCo Inc.
    $PEP
    3/18/2025$168.00 → $156.00Overweight → Equal Weight
    Barclays
    PepsiCo Inc.
    $PEP
    3/12/2025$171.00 → $170.00Buy → Hold
    Jefferies
    PepsiCo Inc.
    $PEP
    1/7/2025$171.00Overweight
    Piper Sandler
    PepsiCo Inc.
    $PEP
    12/12/2024$179.00 → $184.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND INTERIM CEO Umair Muhammad bought $50,001 worth of shares (7,143 units at $7.00), increasing direct ownership by 3% to 277,667 units (SEC Form 4)

    4 - Childrens Place, Inc. (0001041859) (Issuer)

    10/9/25 4:30:15 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Mithaq Capital Spc bought $10,779,027 worth of shares (966,344 units at $11.15) (SEC Form 4) (Amendment)

    4/A - Childrens Place, Inc. (0001041859) (Issuer)

    2/16/24 7:45:52 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Mithaq Capital Spc bought $24,749,525 worth of shares (1,566,475 units at $15.80) and exercised 1,121,300 in-the-money shares at a strike of $16.57 (SEC Form 4) (Amendment)

    4/A - Childrens Place, Inc. (0001041859) (Issuer)

    2/16/24 7:45:00 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $BTAI
    $NSTG
    $PEP
    $PLCE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by BioXcel Therapeutics Inc.

    SCHEDULE 13G/A - BioXcel Therapeutics, Inc. (0001720893) (Subject)

    2/9/26 4:13:17 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioXcel Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer)

    2/6/26 5:00:36 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Synlogic Inc. filed SEC Form 8-K: Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K/A - SYNLOGIC, INC. (0001527599) (Filer)

    1/29/26 9:00:25 AM ET
    $SYBX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PepsiCo upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded PepsiCo from Neutral to Outperform and set a new price target of $179.00

    1/16/26 8:56:28 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo upgraded by Analyst with a new price target

    Analyst upgraded PepsiCo from Neutral to Overweight and set a new price target of $164.00

    12/10/25 8:12:34 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo upgraded by DZ Bank with a new price target

    DZ Bank upgraded PepsiCo from Hold to Buy and set a new price target of $167.00

    10/21/25 7:14:10 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Summerton Rhys was granted 33,898 shares, increasing direct ownership by 234% to 48,391 units (SEC Form 4)

    4 - Childrens Place, Inc. (0001041859) (Issuer)

    2/5/26 4:32:23 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Director Edwards Douglas R was granted 33,898 shares, increasing direct ownership by 141% to 57,922 units (SEC Form 4)

    4 - Childrens Place, Inc. (0001041859) (Issuer)

    2/5/26 4:31:19 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Director Arshad Hussan was granted 33,898 shares, increasing direct ownership by 148% to 56,865 units (SEC Form 4)

    4 - Childrens Place, Inc. (0001041859) (Issuer)

    2/5/26 4:30:27 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $BTAI
    $NSTG
    $PEP
    $PLCE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IGALMI issued to BIOXCEL THERAPEUTICS, INC.

    Submission status for BIOXCEL THERAPEUTICS, INC.'s drug IGALMI (ORIG-1) with active ingredient DEXMEDETOMIDINE has changed to 'Approval' on 04/05/2022. Application Category: NDA, Application Number: 215390, Application Classification: Type 3 - New Dosage Form

    4/6/22 2:18:32 PM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PepsiCo Declares Quarterly Dividend

    PURCHASE, N.Y., Feb. 4, 2026 /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ:PEP) today declared a quarterly dividend of $1.4225 per share of PepsiCo common stock, a 5 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's prior year, previously announced increase in its annualized dividend to $5.69 per share from $5.42 per share, which began with the June 2025 payment. This dividend is payable on March 31, 2026 to shareholders of record at the close of business on March 6, 2026. In addition, on February 3, 2026,

    2/4/26 4:20:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting

    sNDA submission supports the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home (outpatient) setting with IGALMI® Submission timeline supports potential approval of IGALMI® label expansion as early as year-end 2026 NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company built on artificial intelligence ("AI") to develop transformative medicines in neuroscience, today announced it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home

    1/20/26 7:00:00 AM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting

    Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial Officer Mr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing to Support Potential Launch of IGALMI® in At-Home Setting as Early as Year-End 2026 BioXcel Therapeutics on Track to Submit a sNDA for IGALMI® this Month NEW HAVEN, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company built on artificial intelligence ("AI") to develop transformative medicines in neuroscience, today announced the advancement of its commercial planning for IGALMI® in the at-home setting. As part of this, Mark Pavao, a commercial planning and launch advisor with more than 3

    1/12/26 7:00:00 AM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Leadership Updates

    Live Leadership Updates

    View All

    BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting

    Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial Officer Mr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing to Support Potential Launch of IGALMI® in At-Home Setting as Early as Year-End 2026 BioXcel Therapeutics on Track to Submit a sNDA for IGALMI® this Month NEW HAVEN, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company built on artificial intelligence ("AI") to develop transformative medicines in neuroscience, today announced the advancement of its commercial planning for IGALMI® in the at-home setting. As part of this, Mark Pavao, a commercial planning and launch advisor with more than 3

    1/12/26 7:00:00 AM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    7-Eleven, Inc. Announces Retirement of CEO Joe DePinto After More Than 20 Years of Service

    Stan Reynolds and Doug Rosencrans appointed Interim Co-CEOs DALLAS, Dec. 19, 2025 /PRNewswire/ -- 7-Eleven, Inc. (SEI) today announced that Joe DePinto, who has served as CEO of 7-Eleven, Inc. for more than twenty years, will retire from his position, effective as of the end of this year. Stanley (Stan) Reynolds, currently President of SEI, and Douglas (Doug) Rosencrans, currently Executive Vice President & COO of SEI have been appointed Interim Co-CEOs of SEI as of the same date and will serve in this capacity until a successor to Mr. DePinto is appointed. SEI is the North American convenience store business of Seven & I Holdings (7&i).

    12/19/25 7:00:00 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    PepsiCo, Griffith Foods, and Milhão Launch Direct Farmer Incentive Pilot Program in Brazil's Cerrado Region to Advance Regenerative Agriculture

    A pioneering hybrid "Payment for Practice and Payment for Outcomes" model, directly compensating farmers for adopting regenerative agriculture practicesLaunched in Brazil's Cerrado region, one of the world's most biodiverse savannas and a vital agricultural frontier that produces 60% of Brazil's soybeans and a substantial amount of cornThe pilot will cover 7,000 acres, with plans to scale to 30,000 acres, equivalent to PepsiCo's full corn sourcing volume in the region, with a total investment of $1 million over three years.This project aims to contribute to PepsiCo's efforts to spread the adoption of regenerative agriculture, protective and restorative practices across 10 million acres by 20

    11/3/25 8:30:00 AM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Synlogic Inc.

    SC 13G/A - SYNLOGIC, INC. (0001527599) (Subject)

    11/14/24 4:40:57 PM ET
    $SYBX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Children's Place Inc.

    SC 13G/A - Childrens Place, Inc. (0001041859) (Subject)

    11/14/24 4:01:36 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Children's Place Inc.

    SC 13G/A - Childrens Place, Inc. (0001041859) (Subject)

    11/12/24 2:30:13 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $BTAI
    $NSTG
    $PEP
    $PLCE
    Financials

    Live finance-specific insights

    View All

    PepsiCo Declares Quarterly Dividend

    PURCHASE, N.Y., Feb. 4, 2026 /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ:PEP) today declared a quarterly dividend of $1.4225 per share of PepsiCo common stock, a 5 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's prior year, previously announced increase in its annualized dividend to $5.69 per share from $5.42 per share, which began with the June 2025 payment. This dividend is payable on March 31, 2026 to shareholders of record at the close of business on March 6, 2026. In addition, on February 3, 2026,

    2/4/26 4:20:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo Announces Priorities to Enhance Shareholder Value and Provides Preliminary 2026 Financial Outlook

    Highlights suite of innovation, productivity and affordability initiatives at PepsiCo Foods North America to accelerate growth and improve core1 operating margin performanceExpects organic revenue, core constant currency and core earnings per share (EPS) growth to accelerate in fiscal 2026 with strong core operating margin expansionPrioritizes disciplined capital allocation framework, improving free cash flow conversion and increasing cash returns to shareholdersAims to optimize North American supply chain and go-to-market systemsFollows constructive engagement with supportive PepsiCo shareholder Elliott Investment ManagementLive Q&A session at 7:30AM EST on Tuesday, December 9, 2025, with P

    12/8/25 4:30:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples

    PepsiCo Declares Quarterly Dividend

    PURCHASE, N.Y., Nov. 19, 2025 /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ:PEP) today declared a quarterly dividend of $1.4225 per share of PepsiCo common stock, a 5 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's previously announced increase in its annualized dividend to $5.69 per share from $5.42 per share, which began with the June 2025 payment. This dividend is payable on January 6, 2026 to shareholders of record at the close of business on December 5, 2025. PepsiCo has paid consecutive quarterly cash dividends since 1965, and 2025 marked the company's 53rd consecutive annual dividend increase.

    11/19/25 4:49:00 PM ET
    $PEP
    Beverages (Production/Distribution)
    Consumer Staples